πŸ‡ΊπŸ‡Έ FDA
Patent

US 10858363

SGC stimulators

granted A61KA61K31/437A61K31/4985

Quick answer

US patent 10858363 (SGC stimulators) held by Cyclerion Therapeutics, Inc. expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cyclerion Therapeutics, Inc.
Grant date
Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/437, A61K31/4985, A61K31/52, A61P